» Articles » PMID: 22988085

Type II P21-activated Kinases (PAKs) Are Regulated by an Autoinhibitory Pseudosubstrate

Overview
Specialty Science
Date 2012 Sep 19
PMID 22988085
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The type II p21-activated kinases (PAKs) are key effectors of RHO-family GTPases involved in cell motility, survival, and proliferation. Using a structure-guided approach, we discovered that type II PAKs are regulated by an N-terminal autoinhibitory pseudosubstrate motif centered on a critical proline residue, and that this regulation occurs independently of activation loop phosphorylation. We determined six X-ray crystal structures of either full-length PAK4 or its catalytic domain, that demonstrate the molecular basis for pseudosubstrate binding to the active state with phosphorylated activation loop. We show that full-length PAK4 is constitutively autoinhibited, but mutation of the pseudosubstrate releases this inhibition and causes increased phosphorylation of the apoptotic regulation protein Bcl-2/Bcl-X(L) antagonist causing cell death and cellular morphological changes. We also find that PAK6 is regulated by the pseudosubstrate region, indicating a common type II PAK autoregulatory mechanism. Finally, we find Src SH3, but not β-PIX SH3, can activate PAK4. We provide a unique understanding for type II PAK regulation.

Citing Articles

PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner.

Iannotta L, Fasiczka R, Favetta G, Zhao Y, Giusto E, DallAra E Cell Death Dis. 2024; 15(10):752.

PMID: 39419978 PMC: 11487180. DOI: 10.1038/s41419-024-07124-4.


P-21 Activated Kinases in Liver Disorders.

Qiu X, Xu H, Wang K, Gao F, Xu X, He H Cancers (Basel). 2023; 15(2).

PMID: 36672500 PMC: 9857091. DOI: 10.3390/cancers15020551.


Rho family GTPase signaling through type II p21-activated kinases.

Chetty A, Ha B, Boggon T Cell Mol Life Sci. 2022; 79(12):598.

PMID: 36401658 PMC: 10105373. DOI: 10.1007/s00018-022-04618-2.


Molecular basis for integrin adhesion receptor binding to p21-activated kinase 4 (PAK4).

Ha B, Yigit S, Natarajan N, Morse E, Calderwood D, Boggon T Commun Biol. 2022; 5(1):1257.

PMID: 36385162 PMC: 9669019. DOI: 10.1038/s42003-022-04157-3.


p21-Activated Kinase: Role in Gastrointestinal Cancer and Beyond.

Li X, Li F Cancers (Basel). 2022; 14(19).

PMID: 36230657 PMC: 9563254. DOI: 10.3390/cancers14194736.


References
1.
Eswaran J, Soundararajan M, Kumar R, Knapp S . UnPAKing the class differences among p21-activated kinases. Trends Biochem Sci. 2008; 33(8):394-403. DOI: 10.1016/j.tibs.2008.06.002. View

2.
Murray B, Guo C, Piraino J, Westwick J, Zhang C, Lamerdin J . Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proc Natl Acad Sci U S A. 2010; 107(20):9446-51. PMC: 2889050. DOI: 10.1073/pnas.0911863107. View

3.
Ahmed T, Shea K, Masters J, Jones G, Wells C . A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF. Cell Signal. 2008; 20(7):1320-8. DOI: 10.1016/j.cellsig.2008.02.021. View

4.
Manser E, Loo T, Koh C, Zhao Z, Chen X, Tan L . PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol Cell. 1998; 1(2):183-92. DOI: 10.1016/s1097-2765(00)80019-2. View

5.
Pandey A, Dan I, Kristiansen T, Watanabe N, Voldby J, Kajikawa E . Cloning and characterization of PAK5, a novel member of mammalian p21-activated kinase-II subfamily that is predominantly expressed in brain. Oncogene. 2002; 21(24):3939-48. DOI: 10.1038/sj.onc.1205478. View